Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiome in gastrointestinal cancer: a friend or foe?
Yang Liu, Yoshifumi Baba, Takatsugu Ishimoto, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 10, pp. 4101-4117
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance
Xudong Zhu, Shenglong Li
Advanced Science (2023) Vol. 10, Iss. 26
Open Access | Times Cited: 44
Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy
Jiaao Sun, Feng Chen, Guangzhen Wu
The ISME Journal (2023) Vol. 17, Iss. 10, pp. 1535-1551
Open Access | Times Cited: 42
The role of microbiomes in gastrointestinal cancers: new insights
Aref Yarahmadi, Hamed Afkhami
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 10
Akkermansia muciniphila inhibits tryptophan metabolism via the AhR/β-catenin signaling pathway to counter the progression of colorectal cancer
Lu Zhang, Qing Ji, Qian Chen, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 14, pp. 4393-4410
Open Access | Times Cited: 21
Gut Microbiome Composition and Its Metabolites Are a Key Regulating Factor for Malignant Transformation, Metastasis and Antitumor Immunity
Stefan Lozenov, Boris Krastev, Georgi Nikolaev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5978-5978
Open Access | Times Cited: 16
Supplement Use and Increased Risks of Cancer: Unveiling the Other Side of the Coin
Parnian Jabbari, Omid Yazdanpanah, David J. Benjamin, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 880-880
Open Access | Times Cited: 6
Intratumoral bacteria are an important “accomplice” in tumor development and metastasis
Gang Wang, Xianli He, Qian Wang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1878, Iss. 1, pp. 188846-188846
Closed Access | Times Cited: 27
Cracking Brain Diseases from Gut Microbes-Mediated Metabolites for Precise Treatment
Ying Gong, Anmei Chen, Guohui Zhang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 10, pp. 2974-2998
Open Access | Times Cited: 14
The diversity of the microbiome impacts chronic lymphocytic leukemia development in mice and humans
Tereza Faitová, Mariana Coelho, Caspar da Cunha‐Bang, et al.
Haematologica (2024) Vol. 109, Iss. 10, pp. 3237-3250
Open Access | Times Cited: 4
Methylmalonic acid at the serum level in the elderly contributes to cell growth via mitochondrial dysfunction in colorectal cancer cell spheroids
Arowu R. Tanaka, Chiho Murakami, Hideya Yamamoto
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101909-101909
Closed Access
Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids
Ann‐Kathrin Lederer, Nele Görrissen, Tinh Thi Nguyen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
The role of microbiome in gastrointestinal cancer
M. P. Sarath Krishnan, Bela Goyal, Leary Nampui, et al.
International review of cell and molecular biology (2025)
Closed Access
The Use of Gut Organoids: To Study the Physiology and Disease of the Gut Microbiota
Ya Deng, Xiaolu Yuan, Xianmin Lu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 4
Open Access
The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications
Mario Romeo, Marcello Dallio, Filadelfo Nardo, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 124-124
Open Access
The microbiota-m6A-metabolism axis: Implications for therapeutic strategies in gastrointestinal cancers
Xiuxiu Qiu, Qi Gao, Jiahui Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189317-189317
Closed Access
Forces at play: exploring factors affecting the cancer metastasis
Farooq Riaz, Jing Zhang, Fan Pan
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Role of gut microbiota in the pathogenesis of castration-resistant prostate cancer: a comprehensive study using sequencing and animal models
Guo-Wen Lin, Feng Zhang, Xiaoling Weng, et al.
Oncogene (2024) Vol. 43, Iss. 31, pp. 2373-2388
Closed Access | Times Cited: 4
Synergistic Strategies for Gastrointestinal Cancer Care: Unveiling the Benefits of Immunonutrition and Microbiota Modulation
Serena Martinelli, Ingrid Lamminpää, E. Dubus, et al.
Nutrients (2023) Vol. 15, Iss. 20, pp. 4408-4408
Open Access | Times Cited: 10
The Role of Yeasts in Human Health: A Review
Cátia Filipa Caetano, Carlos Gaspar, José Martinez‐de‐Oliveira, et al.
Life (2023) Vol. 13, Iss. 4, pp. 924-924
Open Access | Times Cited: 9
Probiotic-Derived Bioactive Compounds in Colorectal Cancer Treatment
Christina Thoda, Maria Touraki
Microorganisms (2023) Vol. 11, Iss. 8, pp. 1898-1898
Open Access | Times Cited: 9
The role of gut microbiota associated metabolites in digestive disorders
Na Li, Cheng Zhao, Pingnan Zhang, et al.
Engineered Regeneration (2024) Vol. 5, Iss. 2, pp. 228-246
Open Access | Times Cited: 3
Changes in the gut microbiome of patients with esophageal cancer: a systematic review and meta-analysis based on 16S gene sequencing technology
Jieyin Deng, Ye Huang, Ke Yu, et al.
Microbial Pathogenesis (2024) Vol. 193, pp. 106784-106784
Closed Access | Times Cited: 3
Metabolic interactions of host-gut microbiota: New possibilities for the precise diagnosis and therapeutic discovery of gastrointestinal cancer in the future—A review
Jianing Yu, Lu Li, Xufeng Tao, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 203, pp. 104480-104480
Open Access | Times Cited: 3
Existing and emerging biomarkers in hepatocellular carcinoma: relevance in staging, determination of minimal residual disease, and monitoring treatment response: a narrative review
Dana A. Dominguez, Paul Wong, Laleh G. Melstrom
HepatoBiliary Surgery and Nutrition (2023) Vol. 13, Iss. 1, pp. 39-55
Open Access | Times Cited: 7
The potential role of gut microbiota outer membrane vesicles in colorectal cancer
Ran Meng, Minmin Zeng, Ying Ji, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top